Evidence map›Paper›PMID 38318689›Full record

Trial reportAnnals of clinical and translational neurology2024

Pitfalls of using video-EEG for a trial endpoint in children aged <4 years with focal seizures.

Ali Bozorg, Cynthia Beller, Lori Jensen, Alexis Arzimanoglou, Catherine Chiron, Dennis Dlugos, John Gaitanis, James W Wheless, Carrie McClung

2 registry-linked trialsOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Annals of clinical and translational neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01921205 phase3completednot on this map

A Multicenter, Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects With Epilepsy ≥4 Years to <17 Years of Age With Partial Onset Seizures

TypeinterventionalSponsorUCB PharmaRan2013 to 2017Enrolled404ConditionsEpilepsyArmsLacosamide, Placebo
NCT02477839 phase3completednot on this map

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects With Epilepsy >=1 Month to <4 Years of Age With Partial-Onset Seizures

TypeinterventionalSponsorUCB BIOSCIENCES, Inc.Ran2015 to 2020Enrolled255ConditionsEpilepsy With Partial-onset SeizuresArmsLacosamide, Placebo
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 5 countries.

Ali BozorgUCB Pharma, Morrisville, North Carolina, USA.
Cynthia BellerUCB Pharma, Morrisville, North Carolina, USA.
Lori JensenUCB Pharma, Morrisville, North Carolina, USA.
Alexis ArzimanoglouDepartment of Paediatric Clinical Epileptology, Sleep Disorders and Functional Neurology, University Hospitals of Lyon (HCL), Member of the ERN EpiCARE, Lyon, France.
Catherine ChironInserm U1141 and Necker-Enfants Malades Hospital, Paris, France.
Dennis DlugosDepartments of Neurology and Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
John GaitanisTufts Medical Center, Boston, Massachusetts, USA.
James W WhelessLe Bonheur Comprehensive Epilepsy Program & Neuroscience Institute, Le Bonheur Children's Hospital, University of Tennessee Health Science Center, Memphis, Tennessee, USA.ORCID 0000-0002-4735-3431
Carrie McClungUCB Pharma, Morrisville, North Carolina, USA.
UCB Pharma (United States) · USCentre de Recherche en Neurosciences de Lyon · FRChildren's Hospital of Philadelphia · USInserm · FRTufts Medical Center · USUniversity of Tennessee Health Science Center · US

Funding

UCB Pharma
6 · The paper itself

Abstract

objectiveDouble-blind, randomized, and placebo-controlled trial SP0967 (NCT02477839/2013-000717-20) did not demonstrate superior efficacy of lacosamide versus placebo in patients aged ≥1 month to <4 years with uncontrolled focal seizures, per ≤72 h video-electroencephalogram (video-EEG)-based primary endpoints (reduction in average daily frequency of focal seizures at end-of-maintenance [EOM] versus end-of-baseline [EOB], patients with ≥50% response). This was unexpected because randomized controlled trial SP0969 (NCT01921205) showed efficacy of lacosamide in patients aged ≥4 to <17 years with uncontrolled focal seizures. SP0969's primary endpoint was based on seizure diary instead of video-EEG, an issue with the latter being inter-reader variability. We evaluated inter-reader agreement in video-EEG interpretation in SP0967, which to our knowledge, are the first such data for very young children with focal seizures from a placebo-controlled trial.

methodsLocal investigator and central reader agreement in video-EEG interpretation was analyzed post hoc.

resultsAnalysis included 105 EOB and 98 EOM video-EEGs. Local investigators and central reader showed poor agreement based on ≥2 focal seizures at EOB (Kappa = 0.01), and fair agreement based on ≥2 focal seizures at EOM (Kappa = 0.23). Local investigator and central reader seizure count interpretations varied substantially, particularly for focal seizures, but also primary generalized and unclassified epileptic seizures, at both timepoints.

interpretationHigh inter-reader variability and low inter-reader reliability of the interpretation of seizure types and counts prevent confident conclusion regarding the lack of efficacy of lacosamide in this population. We recommend studies in very young children do not employ video-EEGs exclusively for accurate study inclusion or as an efficacy measure.

Indexed as

AnticonvulsantsEpilepsies, PartialChildChild, PreschoolElectroencephalographyHumansLacosamideReproducibility of ResultsSeizuresTreatment OutcomeAnticonvulsantsLacosamide

Identifiers

PMID38318689
PMCPMC10963279
OpenAlexW4391605136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.